| Treatment options for refractory metastatic colorectal cancer are limited. |
| The combination of trifluridine-tipiracil and bevacizumab showed promising activity and safety in clinical trials. |
| Our series provides further evidence on the efficacy and tolerability of this combination in real-world patients. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.